Borealis Dataverse OAI Archive
metadata only
Data for: Mediterranean-ketogenic versus medium-chain triglyceride supplemented Mediterranean diet on the gut-brain-immune axis in Parkinson’s disease
Ketogenic diets have been proposed as potential neuroprotective interventions for Parkinson’s disease (PD), but concerns remain regarding their effects on the gut microbiome and gut–brain–immune axis. We conducted a randomized crossover trial comparing 8-week Mediterranean-ketogenic (MeDi-KD) versus
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome#865484
- Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation#904207
- The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response#811978
- Evaluation of the Ketogenic Potential of Different Diet Supplements#1185229
- Ketone Esters for Appetite, Cognition, and Cardiovascular Function in Individuals With Obesity and Insulin Resistance#1060335
Record · ID 1450984
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive